Thomas DiRaimondo

Insider Reports History

Location
C/O Janux Therapeutics, Inc., 10955 Vista Sorrento Parkway, Suite 200, San Diego, CA
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas DiRaimondo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Scientific Officer Common Stock 130K $7.44M $57.37 Jan 2, 2025 Direct
Janux Therapeutics, Inc. Chief Scientific Officer Stock option (right to buy) 84K Jan 2, 2025 Direct

Insider Reports Filed by Thomas DiRaimondo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JANX Janux Therapeutics, Inc. Jan 2, 2025 2 $0 4 Jan 3, 2025 Chief Scientific Officer
JANX Janux Therapeutics, Inc. Sep 27, 2024 2 -$232K 4 Sep 27, 2024 Chief Scientific Officer
JANX Janux Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 3, 2024 Chief Scientific Officer
JANX Janux Therapeutics, Inc. Jan 1, 2024 0 $0 3 Jan 3, 2024 Chief Scientific Officer